Source:http://linkedlifedata.com/resource/pubmed/id/15489013
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-10-18
|
pubmed:abstractText |
The diagnosis of neurodegenerative diseases with dementias requires several different test approaches and often remains uncertain. Using a proteomic approach it was shown in nine patients that heart fatty acid binding protein (H-FABP) might be a biomarker for Creutzfeldt-Jakob disease (CJD). The aim of our study was to evaluate whether H-FABP is a biomarker for the differential diagnosis of dementias. Therefore we measured H-FABP in cerebrospinal fluid (CSF) and serum of patients having CJD, dementia with Lewy-bodies (DLB), Alzheimer's disease (AD) and in non-demented control (NDC) patients. H-FABP levels in CSF and serum of CJD patients are increased compared to non-demented controls. Levels of H-FABP were significantly higher in CJD patients compared to AD and DLB in CSF. However, discrimination between CJD and AD was not possible in serum. Interestingly, highest levels of H-FABP were found in serum of DLB patients. Our results suggest that H-FABP might be a useful biomarker for the differentiation between the dementias examined if levels in CSF and serum are determined in parallel.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0304-3940
|
pubmed:author |
pubmed-author:BiblMirkoM,
pubmed-author:BrechlinPeterP,
pubmed-author:CepekLukasL,
pubmed-author:EsselmannHermannH,
pubmed-author:KretzschmarHans AHA,
pubmed-author:LewczukPiotrP,
pubmed-author:MollenhauerBritB,
pubmed-author:OttoMarkusM,
pubmed-author:PoserSigridS,
pubmed-author:SteinackerPetraP,
pubmed-author:TrenkwalderClaudiaC,
pubmed-author:WiltfangJensJ
|
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
370
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
36-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15489013-Adult,
pubmed-meshheading:15489013-Aged,
pubmed-meshheading:15489013-Aged, 80 and over,
pubmed-meshheading:15489013-Alzheimer Disease,
pubmed-meshheading:15489013-Biological Markers,
pubmed-meshheading:15489013-Carrier Proteins,
pubmed-meshheading:15489013-Creutzfeldt-Jakob Syndrome,
pubmed-meshheading:15489013-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15489013-Fatty Acid-Binding Proteins,
pubmed-meshheading:15489013-Female,
pubmed-meshheading:15489013-Humans,
pubmed-meshheading:15489013-Lewy Body Disease,
pubmed-meshheading:15489013-Male,
pubmed-meshheading:15489013-Middle Aged,
pubmed-meshheading:15489013-Myocardium,
pubmed-meshheading:15489013-Neurodegenerative Diseases,
pubmed-meshheading:15489013-Statistics, Nonparametric
|
pubmed:year |
2004
|
pubmed:articleTitle |
Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.
|
pubmed:affiliation |
Department of Neurology, University Hospital, Robert-Koch-Str. 40, 37075 Goettingen, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|